[go: up one dir, main page]

GB1346176A - Benzodiazepines - Google Patents

Benzodiazepines

Info

Publication number
GB1346176A
GB1346176A GB1346176DA GB1346176A GB 1346176 A GB1346176 A GB 1346176A GB 1346176D A GB1346176D A GB 1346176DA GB 1346176 A GB1346176 A GB 1346176A
Authority
GB
United Kingdom
Prior art keywords
alkyl
halogen
alkoxy
aug
benzodiazepines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of GB1346176A publication Critical patent/GB1346176A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1346176 Benzodiazepines AMERICAN HOME PRODUCTS CORP 24 Aug 1971 [25 Aug 1970] 40811/70 Heading C2C Benzodiazepine derivatives are prepared by the following routes (R 1 =C 1-8 alkyl, R 2 = C 1-8 alkyl, C 2-9 alkoxycarbonyl or NR 1 R 2 = 1-pyrrolidinyl, piperidino, morpholino; R 3 =H, halogen; R 4 = halogen, C 1-3 alkyl, alkoxy or alkylthio, CN, CF 3 , NO 2 ; R 5 = C 1-8 alkyl; X = halogen; Y = C 1-8 alkoxy; n=2-8). The 3-halo and alkoxy compounds are anticonvulsants, and may be administered in the form of pharmaceutical preparations containing them in association with a carrier.
GB1346176D 1970-08-25 1970-08-25 Benzodiazepines Expired GB1346176A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4081170 1970-08-25

Publications (1)

Publication Number Publication Date
GB1346176A true GB1346176A (en) 1974-02-06

Family

ID=10416740

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1346176D Expired GB1346176A (en) 1970-08-25 1970-08-25 Benzodiazepines

Country Status (1)

Country Link
GB (1) GB1346176A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2846653A1 (en) * 2002-10-30 2004-05-07 Neuro3D Use of new and known phosphodiesterase 2 inhibitors for treating disorders of the nervous system, e.g. Alzheimer's or Parkinson's disease
WO2004041258A3 (en) * 2002-10-30 2004-09-23 Neuro3D Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2846653A1 (en) * 2002-10-30 2004-05-07 Neuro3D Use of new and known phosphodiesterase 2 inhibitors for treating disorders of the nervous system, e.g. Alzheimer's or Parkinson's disease
WO2004041258A3 (en) * 2002-10-30 2004-09-23 Neuro3D Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses
JP2006509832A (en) * 2002-10-30 2006-03-23 ニューロ3デー Cyclic nucleotide phosphodiesterase inhibitors, their preparation and use

Similar Documents

Publication Publication Date Title
GB1249375A (en) Aminobenzocycloalkane compounds
HUT41390A (en) Process for preparing 3-cyan pyridine derivatives and pharmaceutical preparations comprising the same as active substance
IL42781A (en) Derivatives of(4'-(3"-indolyl)piperidino)alkylarylketones,process for preparing them and pharmaceutical compositions containing same
GB1346176A (en) Benzodiazepines
GB1341794A (en) Medicament for the treatment of hepatic disorders
GB1491858A (en) 1,5-dihydro-2h-1,4-benzodiazepin-2-one derivatives and the production thereof
GB1390485A (en) Pyrazoles
GB1350722A (en) Triazolo benzodiazepines
GB1348449A (en) Benzodiazepine derivatives
GB1387606A (en) Triazolobenzodiazepines
GB1248727A (en) Benzodiazepine derivatives
GB1279915A (en) 0-aryl-2,3,4,5-tetrahydro-1h-1,5-benzodiazepine-2-ones and a process for their preparation
GB1360693A (en) Triazolobenzo-diazepines and the manufacture thereof
GB1369342A (en) Benzodiazepine derivatives
GB1306455A (en) Benzodiazepine derivatives and manufacture thereof
GB1474305A (en) Benzodiazepine derivatives
GB1327930A (en) 1,4-benzodiazepine derivatives
GB1297890A (en)
GB1340535A (en) Benzodiazepine derivatives
GB1460680A (en) 1,4-benzodiazepines
GB1217217A (en) Benzodiazepine derivatives
GB1222294A (en) Oxazinobenzodiazepine derivatives
GB1299801A (en) Process for preparing benzodiazepine derivatives and salts thereof
GB1279566A (en) 0,4-benzodiazepine derivative preparation
GB1173701A (en) 5-Substituted-1,4-Benzodiazepines

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee